
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/4F-EPH: Difference between revisions
Jump to navigation
Jump to search
>BronzeManul m Standardising Phenidates to be classed as 'Amphetamine / Piperidine' |
>Mydriasis m Amended common name. |
||
(12 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
{{SubstanceBox | {{SubstanceBox | ||
<!-- | <!-- Special Parameters --> | ||
|MaterialTable_MaxWidth= | |displayClasses={{{displayClasses|}}} | ||
|MaterialTable_MaxWidth=250px | |||
|MaterialTable_Title={{PAGENAME}} | |MaterialTable_Title={{PAGENAME}} | ||
Line 10: | Line 11: | ||
|ModuleStructure=true | |ModuleStructure=true | ||
|ModuleNomenclature=true | |ModuleNomenclature=true | ||
|ModuleClassMembership=true | |||
|ModuleROA=true | |ModuleROA=true | ||
Line 31: | Line 33: | ||
<!-- Structure --> | <!-- Structure --> | ||
|MolecularStructureCaption= | |MolecularStructureCaption=Molecular structure of 4F-EPH | ||
|SkeletalImageFile=File:4F-EPH. | |SkeletalImageFile=File:4F-EPH.svg | ||
|SkeletalImageWidth= | |SkeletalImageWidth=245px | ||
|3DImageFile= | |3DImageFile= | ||
|3DImageWidth= | |3DImageWidth= | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=4F-EPH | |NameCommon=[[common name::4F-EPH]], [[common name::4-FEPH]] | ||
|NameSubstitution= | |NameSubstitution=4-Fluoroethylphenidate | ||
|NameSystematic= | |NameSystematic=Ethyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate | ||
<!-- Class Membership --> | <!-- Class Membership --> | ||
|EffectClass=[[Stimulant]] | |EffectClass=[[psychoactive class::Stimulant]] | ||
|ChemicalClass=[[ | |ChemicalClass= [[chemical class::Phenidate]] | ||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
|OralROA=true | |||
|OralROA_Collapsed=false | |||
|OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation.<br>'''This dosage and duration information has been sourced from [http://drugs.tripsit.me/4-fluoroethylphenidate TripSit]''' | |||
|OralROA_Bioavailability= | |||
|OralROA_Threshold= < [[Oral threshold dose::5]] [[Oral dose units::mg]] | |||
|OralROA_Light=[[Oral min light dose::5]] - [[Oral max light dose::10]] mg | |||
|OralROA_Common=[[Oral min common dose::10]] - [[Oral max common dose::15]] mg | |||
|OralROA_Strong=[[Oral min strong dose::15]] - [[Oral max strong dose::30]] mg | |||
|OralROA_Heavy=[[Oral heavy dose::30]] mg + | |||
|OralROA_TimelineFile= | |||
|OralROA_TimelineWidth= | |||
|OralROA_Duration=[[Oral min total time::5]] - [[Oral max total time::6]] [[Oral total time units::hours]] | |||
|OralROA_Onset=[[Oral min onset time::10]] - [[Oral max onset time::25]] [[Oral onset time units::minutes]] | |||
|OralROA_Peak= | |||
|OralROA_Offset= | |||
|OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::12]] [[Oral afterglow time units::hours]] | |||
}} | }} |
Latest revision as of 12:57, 1 August 2023
SubstanceBox/4F-EPH | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||
Common names | 4F-EPH, 4-FEPH | ||||||||||||||||||||||||||
Substitutive name | 4-Fluoroethylphenidate | ||||||||||||||||||||||||||
Systematic name | Ethyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate | ||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||
Psychoactive class | Stimulant | ||||||||||||||||||||||||||
Chemical class | Phenidate | ||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||
|